We are live on ! Find out more
IMMU

Immunomedics Inc
IMMU

Delisted

IMMU was delisted on the 22nd of October, 2020.

81 hedge funds and large institutions have $145M invested in Immunomedics Inc in 2013 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 31 increasing their positions, 25 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 25

4% less call options, than puts

Call options by funds: $11.8M | Put options by funds: $12.3M

2% less funds holding

Funds holding: 8381 (-2)

20% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 10

30% less capital invested

Capital invested by funds: $208M → $145M (-$63.1M)

Holders
81
Holders Change
-2
Holders Change %
-2.41%
% of All Funds
2.35%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
31
Reduced
25
Closed
10
Calls
$11.8M
Puts
$12.3M
Net Calls
-$535K
Net Calls Change
-$5.69M
Name Holding Trade Value Shares
Change
Change in
Stake
Deutsche Bank
51
Deutsche Bank
Germany
$142K -$483K -108,537 -78%
FHC
52
First Heartland Consultants
Missouri
$141K +$70.3K +15,777 +106%
Commonwealth Equity Services
53
Commonwealth Equity Services
Massachusetts
$139K +$3.79K +850 +3%
T. Rowe Price Associates
54
T. Rowe Price Associates
Maryland
$137K
Barclays
55
Barclays
United Kingdom
$137K +$123K +27,646 +425%
SO
56
STRS Ohio
Ohio
$126K -$14.2K -3,200 -10%
VKH
57
Virtu KCG Holdings
New York
$125K +$122K +27,309 New
HW
58
Hancock Whitney
Mississippi
$121K
UBS AM
59
UBS AM
Illinois
$115K
U
60
UBS
Switzerland
$105K +$89.1K +20,000 +702%
HCM
61
Highbridge Capital Management
New York
$99K +$96.1K +21,590 New
Bank of America
62
Bank of America
North Carolina
$87K +$62.2K +13,975 +278%
Tudor Investment Corp
63
Tudor Investment Corp
Connecticut
$86K +$83.2K +18,678 New
T
64
TradeWorx
New Jersey
$64K +$61.5K +13,811 New
GCP
65
GSA Capital Partners
United Kingdom
$62K -$201K -45,119 -77%
Wells Fargo
66
Wells Fargo
California
$60K -$494 -111 -0.8%
WAM
67
Wolverine Asset Management
Illinois
$38K +$34.3K +7,700 +1,100%
ST
68
Spot Trading
Illinois
$28K +$18.6K +4,184 +224%
Canada Life
69
Canada Life
Manitoba, Canada
$27K
Creative Planning
70
Creative Planning
Kansas
$24K
SSB
71
Sandy Spring Bank
Maryland
$20K
Teacher Retirement System of Texas
72
Teacher Retirement System of Texas
Texas
$14K -$31.4K -7,052 -71%
PA
73
Perceptive Advisors
New York
$13K -$3.27M -734,652 -100%
BlackRock
74
BlackRock
New York
$10K
TRCT
75
Tower Research Capital (TRC)
New York
$9K -$1.69K -380 -17%

IMMU Hedge Fund Activity: Q4 2013 in Review

81 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q4 2013, worth a combined $145M — down 30% from $208M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of IMMU and 8 opened new positions — a net loss of 2 holders — while 25 trimmed existing stakes and 31 added.

The largest buyer was Susquehanna International Group, adding an estimated $1.44M. The largest seller was Sigma Capital Management, cutting an estimated $5.45M.

  • 81 institutional investors held Immunomedics Inc (IMMU) as of Q4 2013, down from 83 in Q3 2013.
  • Funds reported $145M of Immunomedics Inc stock for Q4 2013, down 30% quarter-over-quarter.
  • 8 funds opened new Immunomedics Inc positions in Q4 2013 and 10 closed out, a net change of -2 holders.
  • The largest Immunomedics Inc buyer in Q4 2013 was Susquehanna International Group, an estimated $1.44M added.
  • The largest Immunomedics Inc seller in Q4 2013 was Sigma Capital Management, an estimated $5.45M sold.

Based on aggregated 13F filings for Q4 2013.